Piracetam is an unregistered cognition enhancer widely used to treat neurological disorders. It was sold as a dietary supplement until FDA ordered this practice to be discontinued in 2010. It remains available online and in some US stores. H. Morren reported the synthesis of piracetam in 1966. Earlier this year, D. Croker et al. reported a method to monitor the crystallization of piracetam to ensure that the desired stable polymorph is formed.
Learn more about this molecule from CAS, the most authoritative and comprehensive source for chemical information.
Stay Ahead of the Chemistry Curve
Learn how ACS can help you stay ahead in the world of chemistry.